Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 575,831 | 463,619 | 517,564 | 2,064,602 | 539,012 |
| Cost of Goods | 328,249 | 221,918 | 268,441 | 1,040,985 | 303,645 |
| Gross Profit | 247,582 | 241,701 | 249,123 | 1,023,617 | 235,367 |
| Operating Expenses | 259,120 | 257,304 | 256,415 | 1,112,150 | 284,113 |
| Operating Income | -11,538 | -15,603 | -7,292 | -87,548 | -48,746 |
| Interest Expense | 3,527 | 3,790 | 4,096 | 18,799 | 4,472 |
| Other Income | -16,911 | 442 | 2,303 | 14,813 | 1,306 |
| Pre-tax Income | -31,976 | -18,951 | -9,085 | -91,534 | -51,912 |
| Income Tax | -1,551 | -141 | -443 | -13,572 | -23,890 |
| Net Income Continuous | -30,425 | -18,810 | -8,642 | -77,962 | -28,022 |
| Net Income | $-30,425 | $-18,810 | $-8,642 | $-77,962 | $-28,022 |
| EBITDA(a) | $-11,538 | $-15,603 | $-7,292 | $-87,548 | $-48,746 |